Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Files

844683.pdf (1.13 MB)

Document type

Article

Version

Published version

Publication date

2023-12

Publication license

cc-by-nc-nd (c) Oliveres, Helena et al., 2023
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/219518

Metabolic interventions to enhance immunotherapy and targeted therapy efficacy in advanced colorectal cancer

Journal Title

Authors

Director/Tutor

Journal ISSN

Volume Title

Related resource

https://doi.org/10.1016/j.cbpa.2023.102401

Abstract

Current standard-of-care for metastatic colorectal cancer patients includes chemotherapy and anti-angiogenic or anti-epidermal growth factor receptor for microsatellite stable tumors and pembrolizumab for microsatellite instable tumors. However, despite the available therapies, the prognosis remains poor. In recent years, new drugs combined with immune checkpoint inhibitors have been tested in microsatellite stable metastatic colorectal cancer patients, but the benefit was modest. Here, we review the metabolic interactions between the immune microenvironment and cancer cells. More specifically, we highlight potential correlatives of tumor immune and metabolic features with transcriptomic classifications such as the Consensus Molecular Subtype. Finally, we discuss the unmet need of immune-metabolic signatures and the value of a new signature (IMMETCOLS) for guiding new strategies in metastatic colorectal cancer. We conclude that the field is ready to propose customized strategies for modifying metabolism and improving immunotherapy and targeted therapy efficacy.

Subject

Immunoteràpia, Càncer colorectal, Metabolisme

Subject (English)

Immunotheraphy, Colorectal cancer, Metabolism

Citation

Collections

Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Institut de Biomedicina (IBUB))

Citation

OLIVERES, Helena, CASCANTE I SERRATOSA, Marta and MAUREL SANTASUSANA, Joan. Metabolic interventions to enhance immunotherapy and targeted therapy efficacy in advanced colorectal cancer. Current Opinion in Chemical Biology. 2023. Vol. 77, num. 1-8. ISSN 1367-5931. [consulted: 8 of August of 2026]. Available at: https://hdl.handle.net/2445/219518

Export metadata

JSON - METS

Share record